Lanmark360 in the Top 100 for the seventh straight year
Lanmark360 has been recognized as one of MM&M’s Top 100 Agencies for Medical Marketing and Communications again this year. From multinational holding companies to five-person creative boutique agencies, the Agency 100 remains the industry’s definitive guide – and we are proud to be a part of it.
In the July 2019 issue of MM&M, editor Grace Donnelly spoke with our president, Howard Klein, about some notable transformations and areas where he anticipates new opportunities for agency development and growth.
Howard noted that many healthcare marketing clients are seeking early-stage strategic planning to better define customers and increase the efficiency of their marketing. Most clients are looking for surround-sound, multi-touch digital campaigns, including influencer marketing and video testimonials. Understanding customer drivers and barriers helps illuminate opportunities, increase ROI and drive success.
Even print, direct response, and call center outreach have proven effective at reaching certain patient and physician populations. It all comes from a clear understanding of who your customers are – and where they are. “The ultimate goal is conversion,” Howard stresses.
As we look forward to the months ahead in 2019, Howard anticipates that Lanmark360 will pick up more clients in the earlier stages of drug development. Clients look to Lanmark360 to develop strategies to commercialize small market drugs and devices, create patient content and tactics, organize KOL events, and deploy predictive analytics to help find undiagnosed patients.
Check out the article here and read more about what Lanmark360 president, Howard Klein, has to say about KOL identification, mapping to find digital influencers, and the trend toward establishing strategic goals earlier in the healthcare marketing process – what those developments mean to Lanmark360 and the medical industry as a whole.
View more of our posts